Highlights

Highlights

Subject to update:

  • Lymphocyte engineering for the treatment of Hematological malignancies
  • Lymphocyte engineering for the treatment of Solid tumors
  • Genome editing for allogeneic ACT
  • Safety switches & controlled expression
  • Engineering HSC, NK, NKT and γδ T cells
  • Target & receptor discovery
  • Lymphocyte engineering for the treatment of HIV
  • Optimizing receptor and vector design
  • Non viral vectors and transposons